Global Vaccines Market - Upcoming Trends, Growth Drivers and Challenges – Forecast to -2019-2026
Summary -
A new market
study, titled “Global Vaccines Market
- Upcoming Trends,
Growth Drivers and Challenges – Forecast to -2019-2026” has been featured on WiseGuyReports.
Vaccines are
biological products, acquired immunity to a particular disease or these
products protect people from severe and dreadful diseases. Unlike most other
medicines to treat or cure disease, vaccines prevent them by developing
immunity. Most of the vaccines are administered through injection (intravenous),
a few are given orally and nasal route. The emerging infectious diseases
include Middle East respiratory syndrome coronavirus (MERS-CoV), meningococcal
disease, Ebola, avian flu, swine flu and most recently zika virus.
Market Drivers:
Increase in emerging
infectious diseases prevalence globally, and cost-effective immunizations are
showing a significant impact on global Vaccines market and are also expected to
remain high over the forecast period.
According to WHO in
2017, the annual epidemics in seasonal influenza globally estimated that 3-5
million cases of severe illness and about 290,000-600,000 respiratory deaths
are observed.
According to Centre
Of Disease Control And Prevention in 2016, there were about 360 total cases of
meningococcal disease reported and most among the children below one year old
followed by adults.
Market Segmentation
By Vaccines Type
The global vaccines
market is segmented on vaccines type which includes influenza, measles,
smallpox, yellow fever, hepatitis A, polio, shingles, and others. The other
emerging diseases include ebola, avian flu, and most recently zika virus.
Measles dominated
the vaccines type segment for global vaccines market and expected to remain
dominant during the forecast period due to its global prevalence.
According to WHO in
2017, more than 6.7 million people affected with measles mostly children, and
110,000 died from the virus.
According to Centre
Of Disease Control and Prevention and control, between 2017 and January 2018,
14,372 cases have been registered under European Surveillance System.
By geography
North America
dominates the global vaccines market in 2018, due to the increase in seasonal
influenza viruses around the year in the U.S and government funding for
research on effective vaccines.
According to Centers
Of Disease Control and Prevention during 2017-18 flu season, it was estimated
80,000 Americans died due to seasonal flu, highest in last 40 years.
In 2018, omnibus
bill a single document accepted in a single vote by legislature included $100
million monetary funds to National Institute Of Health (NIH) for the advanced
development of universal influenza vaccine.
By age group
The global vaccines
market is segmented on age group which includes pediatrics, adults, and
geriatrics. Pediatrics dominates the global vaccines market due to its increase
in need of polio vaccines and first stage of vaccines and government regulations.
Infants are
sensitive towards vaccine-preventable diseases because of the early immune
system development, therefore less able to fight against infection. The series
of vaccinations include Hepatitis B, polio, DTaP and DTP vaccine, rotavirus.
These provide best and safest protection against deadly diseases.
Competitive
Landscape
New vaccine launch,
joint ventures between major companies and FDA approvals on new vaccines are
driving the global vaccines market.
In December 2018,
Merck & company got FDA approval for a six disease combination vaccine
vaxelis, for use in children up to the age of five years old.
In October 2018, FDA
approved HPV vaccine which prevents cervical cancer, and other malignancies are
extended for use in men and women aged between 27-45 years.
In April 2018,
Emergent Biosolutionss acquired specialty vaccines company PaxVax.
In October 2017, FDA
approved new shingles vaccine called Shingrix, used to treat blistering disease
for the adult aged 50 and above.
In December 2016,
international vaccine institutes invested $34million in Pennsylvania biotech
inovio to expand its development into MERS-CoV vaccine.
Target Audience
• Raw Material
Suppliers/ Buyers
• Product Suppliers/
Buyers
• Industry
Investors/Investment Bankers
• Education & Research
Institutes
• Research
Professionals
• Emerging Companies
• Manufacturer
About Us:
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and governments
around the globe.
Contact Us:
NORAH
TRENT
Ph: +162-825-80070
(US)
Ph: +44 2035002763 (UK)
Comments
Post a Comment